Egerton Capital (UK) LLP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001581811
What is a 13F filing? Who files one and when · What 13F filings can't tell you
John Armitage — tracked via quarterly SEC 13F filings · All famous investors
Q3 2024 · 30 positions · Total reported value $9.91B · Top-10 concentration 58.7% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 66.7% · 4 new · 10 cut · 4 exited
Active Share (vs S&P 500): 80.2% · vs QQQ: 82.4% — share of the book that differs from index weights (higher = more active) · ranking
In its Q3 2024 13F filing, Egerton Capital (UK) LLP disclosed 30 equity positions with a combined reported value of $9.91B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 58.7% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.
The largest disclosed positions as of Q3 2024 were MSFT ($740.14M), PGR ($716.59M), CP ($671.97M). By sector, the heaviest allocations are Technology 29.9%, Financials 27.0%. Versus the prior quarter, allocation shifted toward Financials (+6.0pp), Technology (+1.6pp) and away from Industrials (-1.8pp), Energy (-2.0pp).
Versus the prior quarter, Egerton Capital (UK) LLP opened 4 new positions, trimmed 10 and fully exited 4, a turnover rate of 66.7% of positions. The portfolio's overlap with the prior quarter was 75% of names.
The largest new positions opened in Q3 2024 were EMBJ ($131.14M), MLM ($110.17M), VRTX ($57.69M).
Of the 4 positions fully exited versus the prior quarter, the largest were CNI ($480.40M), CVE ($202.95M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2024)
- EMBJ EMBRAER SA · $131.14M
- MLM MARTIN MARIETTA MATLS INC · $110.17M
- VRTX VERTEX PHARMACEUTICALS INC · $57.69M
- AAPL APPLE INC · $47.00M
- ARMK ARAMARK · $45.78M
- CB CHUBB LIMITED · $42.90M
Insider Transactions (Form 4)
Latest John Armitage buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Egerton Capital (UK) LLP, based in London, United Kingdom, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 23 positions worth $10.35B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: LONDON, United Kingdom
- SEC registration: 801-72167 (status: Approved), registered 2011-02-25
- Regulatory AUM (Form ADV): $19.12B as of 2026-05-21
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 3 private funds, of which 3 hedge funds
- Website: egertoncapital.com
Portfolio Structure
- 23 positions · $10.35B reported value (Q2 2026)
- Top 10 holdings = 76.0% of reported value
- Largest position: V (VISA INC) at 14.1%
- Average position size: $450.06M
Sector Tilt
- Information Technology 29.8%
- Consumer Discretionary 25.8%
- Financials 15.3%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 5 new, 12 added, 5 reduced, 6 exited
- 1 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.72M | $740.14M | 7.47% | Add | |
| 2 |
|
2.82M | $716.59M | 7.23% | Add | |
| 3 |
|
7.86M | $671.97M | 6.78% | Reduce | |
| 4 |
|
1.03M | $588.75M | 5.94% | Reduce | |
| 5 |
|
3.07M | $571.68M | 5.77% | Reduce | |
| 6 |
|
3.26M | $545.71M | 5.51% | Add | |
| 7 |
|
5.68M | $533.07M | 5.38% | Reduce | |
| 8 |
|
1.89M | $516.04M | 5.21% | Add | |
| 9 |
|
3.38M | $471.39M | 4.76% | Add | |
| 10 |
|
2.58M | $463.22M | 4.67% | Reduce | |
| 11 |
|
248.81K | $458.04M | 4.62% | Reduce | |
| 12 |
|
1.82M | $430.79M | 4.35% | Add | |
| 13 |
|
4.42M | $409.51M | 4.13% | Add | |
| 14 |
|
1.96M | $369.02M | 3.72% | Reduce | |
| 15 |
|
3.17M | $354.80M | 3.58% | Reduce | |
| 16 |
|
1.18M | $324.46M | 3.27% | Reduce | |
| 17 |
|
634.70K | $313.42M | 3.16% | Add | |
| 18 |
|
64.31K | $270.89M | 2.73% | Reduce | |
| 19 |
|
3.38M | $254.11M | 2.56% | Add | |
| 20 |
|
597.86K | $152.44M | 1.54% | Reduce | |
| 21 |
|
3.71M | $131.14M | 1.32% | New | |
| 22 |
|
3.96M | $118.31M | 1.19% | Reduce | |
| 23 |
|
204.67K | $110.17M | 1.11% | New | |
| 24 |
|
405.32K | $93.43M | 0.94% | Reduce | |
| 25 |
|
348.16K | $86.85M | 0.88% | Reduce | |
| 26 |
|
124.05K | $57.69M | 0.58% | New | |
| 27 |
|
201.74K | $47.00M | 0.47% | New | |
| 28 |
|
1.18M | $45.78M | 0.46% | New | |
| 29 |
|
148.76K | $42.90M | 0.43% | New | |
| 30 |
|
177.19K | $19.26M | 0.19% | Reduce | |
FAQ
What did Egerton Capital (UK) LLP buy in 2024-Q3?
In its 2024-Q3 13F filing, Egerton Capital (UK) LLP reported 30 equity positions worth $9.91B in aggregate; its largest disclosed positions were MSFT ($740.14M), PGR ($716.59M), CP ($671.97M).
How large is Egerton Capital (UK) LLP's portfolio?
Egerton Capital (UK) LLP reported $9.91B of long equity holdings across 30 positions as of 2024-Q3. Top-10 holdings account for 58.7% of reported value.
What is Egerton Capital (UK) LLP's investment style?
HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.